Issue link: https://viewer.e-digitaledition.com/i/1367011
+ M e t f o r m i n i s n o t a s u c c e s s f u l fer tility drug for PCOS patients as previously believed. In addition, severa l physiolog ica l studies show that PCOS is a prediabetic condition and often leads to Type 2 diabe- tes. "Our work has been critical to learning that we recommend screening women for diabetes," Dr. Legro says. CONTINUAL LEARNING PCOS resea rch i s on goi n g at Pen n State Health and Penn State College of Medicine. Dr. Legro is the principal inves- tigator of two major NIH-funded PCOS studies currently underway to examine interventions for long-term health: 1. The COMET-PCOS clinica l tria l compa res the effects of ora l con- traceptive pills with metformin on metabolic risk factors in overweight and obese women. 2. The INSUPP-PCOS study looks at the effects of different doses of a com- monly used supplement, inositol, on testosterone and glucose levels and t he possibi lit y of using it to treat chronic PCOS. Advanced technology also plays a large part in these evolving research efforts. A s new technolog y emerges, such as ultrasonography to diagnose polycystic ovaries, so do new studies. "Ultrasound is more sensitive now than it was 20 years ago, and that has to be considered when we diagnose [PCOS]," Dr. Butts asserts. "That 's a matter of ongoing research." When it comes to PCOS, doctors are also trying to understand what factors might contribute to certain women devel- oping the condition, such as genetics and environmental exposures. "If you're exposed to certain environ- mental factors as a small child, that might set the stage in addition to certain genes that might put you at risk. Those are some things we're trying to understand," Dr. Butts says. "If we can define those exposures, we can reduce those that can cause problems later down the road. Those studies are hard to do and take a long time. But I'm hopeful this kind of research can be done and funded and give us some results to help women." SIGNIFICANT STRIDES IN ENDOMETRIOSIS CARE Penn State Health is also a trailblazer in endometriosis treatment and research, including one area of study that focuses on diagnosis. Although endometriosis affects more than 11% of women between the ages of 15 and 44 in the United States, it is often not diagnosed until years after the onset of symptoms. On average, it takes about seven years for an accurate diagnosis, largely because laparoscopic surger y is currently the only way to confirm a diagnosis of endometriosis. "Many physicians often ask patients to try a lot of medical therapy to move toward laparoscopy, but having a confirmed diag- nosis of endometriosis can help patients cope with their disease and understand it better," says Kristin Riley, MD, Interim Chief Resident of Minimally Invasive Gynecologic Surgery at Penn State Health Women's Health. "Having a definitive d ia g nosi s i s i mpor t a nt for g u id i n g their care." A n e w s t u d y, l e d b y T i m o t h y D ei m l i n g , M D, FAC O G , a s s o c i a t e professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Penn State College of Medicine, exam- ines biomarkers as a less invasive way to diagnose endometriosis. Because a limiting factor in research of the disease has been the small, select nature of patient groups studied, this study aims to gather tissue samples from patients across the world and store them in a tissue bank for analysis. O t her st udies focus on treatment options, such as cannabidiol (CBD) for the management of chronic pelvic pain. "CBD hasn't gotten much research," Dr. Riley says. "It's exciting to be one of the first places to have a study like that." A nother study led by Dr. Riley a nd completed several years ago compared surgica l excision and ablation for the treatment of chronic pelvic pain associ- ated with endometriosis. " We fou nd t here i s no d i f ferenc e whether you do excision or ablation — patients had good outcomes either way," Dr. R iley says. " My research is largely driven by patients. A lot of my infertility studies were driven by my patients looking for better treatments." — RICHARD LEGRO, MD, FACOG, CHAIR OF THE DEPARTMENT OF OBSTETRICS AND GYNECOLOGY, PENN STATE COLLEGE OF MEDICINE Timothy Deimling, MD, associate professor and vice chair for research, Department of Obstetrics and Gynecology, Penn State College of Medicine. M D N E W S . C O M /// M D N E W S M i D - P E N N ■ 2 0 21 0 9

